Mirati Therapeutics, Inc. EBITDA Margin 2013-2023 | MRTX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Mirati Therapeutics, Inc. (MRTX) over the last 10 years. The current EBITDA margin for Mirati Therapeutics, Inc. as of September 30, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-09-30 | $0.04B | $-0.78B | -2057.89% |
| 2023-06-30 | $0.03B | $-0.79B | -2933.33% |
| 2023-03-31 | $0.02B | $-0.78B | -4311.11% |
| 2022-12-31 | $0.01B | $-0.76B | -6341.67% |
| 2022-09-30 | $0.01B | $-0.74B | -6736.36% |
| 2022-06-30 | $0.08B | $-0.63B | -810.26% |
| 2021-09-30 | $0.07B | $-0.48B | -645.95% |
| 2020-12-31 | $0.01B | $-0.37B | -2846.15% |
| 2020-09-30 | $0.01B | $-0.34B | -2825.00% |
| 2020-03-31 | $0.00B | $-0.27B | -9066.67% |
| 2019-12-31 | $0.00B | $-0.23B | -5650.00% |
| 2019-09-30 | $0.01B | $-0.18B | -3016.67% |
| 2018-12-31 | $0.01B | $-0.10B | -858.33% |
